Modulation of D-penicillamine-induced autoimmunity in the Brown Norway rat using pharmacological agents that interfere with arachidonic acid metabolism or synthesis of inducible nitric oxide synthase

Toxicology

Volumn 190, Issue 3, 2003, Pages 267-278

  Seguin, Beatrice ^a   Teranishi, Munehiro ^b   Uetrecht, Jack P ^a,c  

^a UNIVERSITY OF TORONTO   (Canada)

^b DAIICHI SANKYO CO   (Japan)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

Aminoguanidine; Autoimmunity; D Penicillamine; Idiosyncratic drug reactions; Misoprostol; Nitric oxide; NSAIDs; Prostaglandin E

Indexed keywords

AMINOGUANIDINE; ANALAR; CYCLOOXYGENASE 2 INHIBITOR; DICLOFENAC; KETOPROFEN; MISOPROSTOL; MONTELUKAST; NITRIC OXIDE SYNTHASE; NONSTEROID ANTIINFLAMMATORY AGENT; PENICILLAMINE; PROSTAGLANDIN; ROFECOXIB; SINGULAR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC PROPHYLAXIS; ANTIINFLAMMATORY ACTIVITY; ARACHIDONIC ACID METABOLISM; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; DRUG INDUCED DISEASE; DRUG POTENTIATION; DRUG SENSITIZATION; INFECTION PREVENTION; MALE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS INHIBITION; PROVOCATION TEST; RAT; RAT STRAIN; SINGLE DRUG DOSE; SPECIES COMPARISON;

ANIMALIA; RATTUS NORVEGICUS;

EID: 0043125586     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-483X(03)00160-4     Document Type: Article

References (23)

1. Chan C.C., Boyce S., Brideau C., Charleson S., Cromlish W., Ethier W., Evans J., Ford-Hutchinson A.W., Forrest M.J., Gauthier J.Y., Gordon R., Gresser M., Gauy J., Kargman S., Kennedy B., Leger S., Mancini J., O'Neill G.P., Ouellet M., Patrick D., Percival M.D., Perrier H., Prasit P., Rodger I., Tagari P., Therien M., Vickers P., Visco D., Wang Z., Webb J., Wong E., Xu L.-J., Young R.N., Zamboni R., Riendeau D. Rofecoxib [Vioxx, MK-0966; 4-(4′-methylsulfonylphenyl)-3-phenyl-2-(5H)-furanone]: a potent and orally active cyclooxygenase-2 inhibitor. Pharmacological and biochemical profiles. J. Pharmacol. Exp. Ther. 290:1999;551-560.
2. Donker A.J., Venuto R.C., Vladutiu A.O., Brentjens J.R., Andres G.A. Effects of prolonged administration of D-penicillamine or captopril in various strains of rats. Brown Norway rats treated with D-penicillamine develop autoantibodies, circulating immune complexes, and disseminated intravascular coagulation. Clin. Immunol. Immunopathol. 30:1984;142-155.
3. Drummer O.H., Routley L., Christophidis N. Reversibility of disulfide formation. Comparison of chemical and enzyme-mediated reduction of penicillamine and captopril disulfides. Biochem. Pharmacol. 36:1987;1197-1201.
4. Emery P., Panayi G. Penicillamine nephropathy. Br. Med. J. (Clin. Res. Ed.). 296:1988;1538.
5. Gilroy D.W., Colville-Nash P.R., Willis D., Chivers J., Paul-Clark M.J., Willoughby D.A. Inducible cyclooxygenase may have anti-inflammatory properties. Nat. Med. 5:1999;698-701.
6. Goldstein R.A., Patterson R. Drug allergy: prevention, diagnosis, and treatment. Ann. Intern. Med. 100:1984;302-303.
7. Halpin R.A., Geer L.A., Zhang K.E., Marks T.M., Dean D.C., Jones A.N., Melillo D., Doss G., Vyas K.P. The absorption, distribution, metabolism and excretion of rofecoxib, a potent and selective cyclooxygenase-2 inhibitor, in rats and dogs. Drug Metab. Dispos. 28:2000;1244-1254.
8. Ihaku D., Cameron L., Suzuki M., Molet S., Martin J., Hamid Q. Montelukast, a leukotriene receptor antagonist, inhibits the late airway response to antigen, airway eosinophilia, and IL-5-expressing cells in Brown Norway rats. J. Allergy Clin. Immun. 104:1999;1147-1154.
9. Julou, L., Guyonnet, J.C., Ducrot, R., Fournel, J., Pasquet, J., 1976. Ketoprofen (19.583 R.P.) (2-(3-benzoylphenyl)-propionic acid). Main pharmacological properties - outline of toxicological and pharmacokinetic data. Scand. J. Rheumatol. (Suppl. 14), 33-44.
10. Lazarou J., Pomeranz B.H., Corey P.N. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. J. Am. Med Assoc. 279:1998;1200-1205.
11. Lehmann J.M., Lenhard J.M., Oliver B.B., Ringold G.M., Kliewer S.A. Peroxisome proliferator-activated receptors alpha and gamma are activated by indomethacin and other non-steroidal anti-inflammatory drugs. J. Biol. Chem. 272:1997;3406-3410.
12. Melarange R., Blower P., Spangler R. Comparison of the anti-inflammatory activity and gastrointestinal irritancy of nabumetone, ibuprofen, and diclofenac in rats following chronic administration. Eur. J. Rheumatol. Inflamm. 14:1994;23-27.
13. Morel P.A., Oriss T.B. Crossregulation between Th1 and Th2 cells. Crit. Rev. Immunol. 18:1998;275-303.
14. Park B.K., Pirmohamed M., Kitteringham N.R. Role of drug disposition in drug hypersensitivity: a chemical, molecular, and clinical perspective. Chem. Res. Toxicol. 11:1998;969-988.
15. Parinaud J., Blanc M., Fournie A., Bierme S., Grandjean H. A flourimetric enzyme-linked immunoassay (FEIA) for measurement of anti-D antibodies. Nouv. Rev. fr. Hematol. 26:(5):1984;299-302.
16. Peris-Ribera J.E., Torres-Molina F., Garcia-Carbonell M.C., Aristorena J.C., Pla-Delfina J.M. Pharmacokinetics and bioavailability of diclofenac in the rat. J. Pharmacokinet. Biopharm. 19:1991;647-665.
17. Reilly T.P., Brady J.N., Marchick M.R., Bourdi M., George J.W., Radonovich M.F., Pise-Masison C.A., Pohl L.R. A protective role for cyclooxygenase-2 in drug-induced liver injury in mice. Chem. Res. Toxicol. 14:2001;1620-1628.
18. Reuter B.K., Cirino G., Wallace J.L. Markedly reduced intestinal toxicity of a diclofenac derivative. Life Sci. 55:1994;L1-L8.
19. Riendeau D., Percival M.D., Boyce S., Brideau C., Charleson S., Cromlish W., Ethier D., Evans J., Falgueyret J.P., Ford-Hutchinson A.W., Gordon R., Greig G., Gresser M., Guay J., Kargman S., Leger S., Mancini J.A., O'Neill G., Ouellet M., Rodger I.W., Therien M., Wang Z., Webb J.K., Wong E., Xu L., Young R.N., Zamboni R., Parasit P., Chan C.C. Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor. Br. J. Pharmacol. 121:1997;105-117.
20. Sayeh E., Uetrecht J.P. Factors that modify penicillamine-induced autoimmunity in Brown Norway rats: failure of the Th1/Th2 paradigm. Toxicology. 163:2001;195-211.
21. Shalev A., Greenberg A.H., Mc Alpine P.J. Detection of attograms of antigen by a high-sensitivity enzyme-linked immunoabsornbent assay (HS-ELISA) using a fluorogenic substrate. J. Immunol. Methods. 38:(1-2):1980;125-139.
22. 2-induced autoimmunity. J. Immunol. 144:1990;2985-2991.
23. Willoughby D.A., Moore A.R., Colville-Nash P.R., Gilroy D. Resolution of inflammation. Int. J. Immunopharmacol. 22:2000;1131-1135.